The Global Cancer Genomics Consortium: Interfacing genomics and cancer medicine

Cancer Research

Volumn 72, Issue 15, 2012, Pages 3720-3724

  Eswaran, Jeyanthy ^a   Gupta, Sudeep ^b   Dutt, Amit ^b   Toi, Masakazu ^c   Pillai, M Radhakrishna ^d   Costa, Luis ^e   Knapp, Stefan ^f   Badwe, Rajendra ^b   Kumar, Rakesh ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b TATA MEMORIAL HOSPITAL   (India)

^c KYOTO UNIVERSITY   (Japan)

^d RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^e HOSPITAL DE SANTA MARIA   (Portugal)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

CANCER GENETICS; CANCER RESEARCH; CONFERENCE PAPER; EGFR GENE; GENE EXPRESSION; GENE TECHNOLOGY; GENETIC VARIABILITY; GLIOMA; HUMAN; INFORMATION TECHNOLOGY; INTERNATIONAL COOPERATION; MICROARRAY ANALYSIS; MOLECULARLY TARGETED THERAPY; MUTATOR GENE; NONHUMAN; PRIORITY JOURNAL; PROFESSIONAL DELEGATION; PROFESSIONAL KNOWLEDGE; PUBLIC-PRIVATE PARTNERSHIP; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION; TRANSLATIONAL RESEARCH; TUMOR GENE;

CONGRESSES AS TOPIC; GENES, NEOPLASM; GENOME, HUMAN; GENOMICS; HUMANS; INDIA; INTERNATIONAL COOPERATION; MEDICAL ONCOLOGY; NEOPLASMS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; SOCIETIES, MEDICAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84864859090     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1054     Document Type: Conference Paper

References (21)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
3. Laird PW. Cancer epigenetics. Hum Mol Genet 2005;14 Spec No 1: R65-76.
4. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
5. Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science 2011;331:1553-8.
6. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 2011;11:726-34.
7. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009;10:57-63.
8. Garber M, Grabherr MG, Guttman M, Trapnell C. Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods 2011;8:469-77.
9. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011;17:330-9.
10. La Thangue NB, Kerr DJ. Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat Rev Clin Oncol 2011;8:587-96.
11. Germano S, O'Driscoll L. Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine. Curr Cancer Drug Targets 2009;9:398-418.
12. Kumar NK, Quach U, Thorsteinsdottir H, Somsekhar H, Daar AS, Singer PA. Indian biotechnology-rapidly evolving and industry led. Nat Biotechnol 2004;22 Suppl:DC31-6.
13. Dhawan J, Gokhale RS, Verma IM. Bioscience in India: times are changing. Cell 2005;123:743-5.
14. Eswaran J, Cyanam D, Mudvari P, Reddy SD, Pakala SB, Nair SS, et al. Transcriptomic landscape of breast cancers through mRNA sequencing. Sci Rep 2012;2:264.
15. Medvedev P, Stanciu M, Brudno M. Computational methods for discovering structural variation with next-generation sequencing. Nat Methods 2009;6:S13-20.
16. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. Selective inhibition of BET bromodomains. Nature 2010;468:1067-73.
17. Fedorov O, Huber K, Eisenreich A, Filippakopoulos P, King O, Bullock AN, et al. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol 2011;18:67-76.
18. Soundararajan M, Eswaran J. Atypical GTPases as drug targets. Anticancer Agents Med Chem 2012;12:19-28.
19. Toi M, Yamashiro H, Tsuji W. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer. Breast Cancer 2009;16:207-18.
20. Casimiro S, Luis I, Fernandes A, Pires R, Pinto A, Gouveia AG, et al. Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clin Exp Metastasis 2012;29:155-64.
21. Badwe R, Hawaldar R, Parmar V, Nadkarni M, Shet T, Desai S. Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. J Clin Oncol 2011;29:2845-51.